Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Short-term Investments (2019 - 2025)

Sunshine Biopharma (SBFM) has disclosed Short-term Investments for 5 consecutive years, with $70457.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Short-term Investments changed N/A year-over-year to $70457.0, compared with a TTM value of $70457.0 through Mar 2025, changed N/A, and an annual FY2021 reading of $7590.0, changed 0.0% over the prior year.
  • Short-term Investments was $70457.0 for Q1 2025 at Sunshine Biopharma, up from $7590.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $70457.0 in Q1 2025 and bottomed at $7590.0 in Q1 2021.
  • Average Short-term Investments over 3 years is $15448.4, with a median of $7590.0 recorded in 2021.
  • Peak annual rise in Short-term Investments hit 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
  • Year by year, Short-term Investments stood at $7590.0 in 2021, then changed by 0.0% to $7590.0 in 2022, then soared by 828.29% to $70457.0 in 2025.
  • Business Quant data shows Short-term Investments for SBFM at $70457.0 in Q1 2025, $7590.0 in Q3 2022, and $7590.0 in Q2 2022.